Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
05/2005
05/17/2005US6894157 Guanylate binding protein (GBP-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation
05/17/2005US6894155 Immumodulatory protein for use in the treatment of nervous system, skin and immunological disorders
05/17/2005US6894147 Intermediate conductance calcium-activated potassium channels (IK1)
05/17/2005US6894035 Adhesive N,O-carboxymethylchitosan coatings which inhibit attachment of substrate-dependent cells and proteins
05/17/2005US6893881 Using paramagnetic particles/Fc recognizing antibodies; for cancer/tumor diagnosis from blood/bone marrow samples without unspecific binding
05/17/2005US6893873 Culturing explants included a culture medium supplemented with vitamin B12, vitamin E, or an organic acids selected from alpha-ketoglutaric acid. para-aminobenzoic acid, or pyruvic acid
05/17/2005US6893872 Pesticidal toxins
05/17/2005US6893871 Human ovarian mesothelial cells and methods of isolation and uses thereof
05/17/2005US6893869 For treatment of cancer/tumors/fungal/viral infections; tumor associated antigens; genetic engineering
05/17/2005US6893867 Molecular switch for regulating mammalian gene expression
05/17/2005US6893865 Methods, compositions, and cells for encapsidating recombinant vectors in AAV particles
05/17/2005US6893858 Human kcnq5 potassium channel, methods and compositions thereof
05/17/2005US6893844 DNA encoding a new human hepatoma derived growth factor and producing method thereof
05/17/2005US6893841 Nucleotide sequences coding polypeptide for use in tool in treatment of defects in protein transport
05/17/2005US6893840 Cytomegalovirus Intron A fragments
05/17/2005US6893838 DADD, death activator death domain protein
05/17/2005US6893836 Ejecting cells from fluid; obtain fluid which contains cells, expose fluid to focus energy projection, recover cells ejected from fluid
05/17/2005US6893833 Use of NAD(P)H oxidase inhibitors to increase cellular uptake of glucose and in the treatment and/or prevention of diseases caused by insulin resistance or diseases related thereto, such as type II diabetes
05/17/2005US6893827 Receptor function assay for G-protein coupled receptors and orphan receptors by reporter enzyme mutant complementation
05/17/2005US6893813 Methods for treatment of HIV and other infections using a T cell or viral activator and anti-retroviral combination therapy
05/17/2005US6893812 Three-dimensional ex vivo angiogenesis system
05/17/2005US6893653 Bioremodelable collagenous, telopeptide, tissue matrix composition; prosthetics; tissue engineering
05/17/2005US6893643 Comprises exogenous nucleotide sequences which encode exogenous amino acid sequences; infection of host cell with recombinant Yellow Fever Virus provides for expression of exogenous nucleic acid and production of antigen
05/17/2005US6893638 Methods for treating b cell lymphoma using CD80-specific antibodies
05/17/2005US6893634 Without inflammatory or other immune response side effects; injection or implantation in tissue containing cancer growth; porous cellulose sulphate and polydimethyldiallylammonium membrane; breast and/or pancreatic tumors
05/17/2005US6893633 Methods and compositions for promoting the maturation of monocytes
05/17/2005CA2375673C Dna sequences derived from the genome of the papillomavirus hpv39, their application to in vitro diagnostic and to the production of immunogen compositions
05/17/2005CA2202390C Keratinocyte growth factor analogs
05/12/2005WO2005043155A1 System and method for the treatment of cancer, including cancers of the central nervous system
05/12/2005WO2005042768A2 Method for maintaining low shear in a bioprocessing system
05/12/2005WO2005042740A1 Method of enhancing hematopoiesis-supporting ability of immortalized human bone marrow stroma cell by transferring indian hedgehog gene
05/12/2005WO2005042736A1 Cell culture supplement for the in vitro cultivation of cells and a method for culturing cells
05/12/2005WO2005042732A2 STABLE CELL LINES EXPRESSING HERG1a AND HERG1b
05/12/2005WO2005042731A1 Methods for purifying hematopoietic stem cells
05/12/2005WO2005042730A2 Method and system for preparing stem cells from fat tissue
05/12/2005WO2005042729A1 Isolated cd4+ t cells defined by cmrf-35 and cd45ro
05/12/2005WO2005042728A2 Immortalized avian cell lines for virus production
05/12/2005WO2005042727A2 Methods of organ regeneration
05/12/2005WO2005042723A2 Novel multipotent stem cells and use thereof
05/12/2005WO2005042703A2 Placental stem cells and uses thereof
05/12/2005WO2005042693A2 Hla-e chimeric molecule
05/12/2005WO2005042581A2 Modified anti-cd52 antibody
05/12/2005WO2005042046A1 Hydrogel providing cell-specific ingrowth
05/12/2005WO2005041972A1 Phosphodiesterase 9 inhibition as treatment for obesity-related conditions
05/12/2005WO2005041942A2 Three-dimensional mammalian ovarian follicular cell and ovarian follicle culture systems in a biocompatible matrix
05/12/2005WO2005041891A2 Neutrophil activation by immune response modifier compounds
05/12/2005WO2005041880A2 RhPV AS A MODEL FOR HPV-INDUCED CANCERS
05/12/2005WO2005041859A2 Conjugates and compositions for cellular delivery.
05/12/2005WO2005041656A2 Methods, compositions and devices for inducing stasis in tissues and organs
05/12/2005WO2005041655A1 Methods, compositions and devices for inducing stasis in cells, tissues, organs, and organisms
05/12/2005WO2005021777A3 Uses of spatial configuration to modulate protein function
05/12/2005WO2005012530A3 Antagonists and agonists of ldcam and methods of use
05/12/2005WO2005005662A3 Secreted proteins as markers for cell differentiation
05/12/2005WO2005004804A3 Compositions and methods for selective dissolution of nascent intravascular blood clots
05/12/2005WO2004101776A3 Novel uses of ppar modulators and professional apcs manipulated by the same
05/12/2005WO2004090120A3 Stem cells having increased sensitivity to sdf-1 and methods of generating and using same
05/12/2005WO2004084828A3 Keratinocyte-fibrocyte concomitant grafting for wound healing
05/12/2005WO2004078944A3 Thrombin, soluble jaggedi, and trap and growth of stem cells
05/12/2005WO2004076631A3 Biologically active native biomatrix composition
05/12/2005WO2004074435A3 Methods for identifying and administering agents that bias the immune response via dendritic cells
05/12/2005WO2004044137A3 Modified oligomeric compounds and compositions for use in gene modulation
05/12/2005WO2003076601A8 Avian cell lines for the production of useful substances
05/12/2005WO2003022126A3 Compositions and methods for the therapy and diagnosis of colon cancer
05/12/2005WO2003012056A3 Carotenoid ketolase gene
05/12/2005WO2001079525A3 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
05/12/2005US20050102719 Sustained totipotent culture of selected monocot genera
05/12/2005US20050102717 Crop plant cystatin proteinase inhibitors and methods of use
05/12/2005US20050102714 hybrid cotton seeds and plants having male sterility, herbicide, insect and disease resistance; transgenic plants
05/12/2005US20050102713 Expression vector comprising regulatory sequences associated with expression of antifungal protein for use as tool in generating transgenic plants with enhanced exogeneous gene transcription and insect and herbicide resistance
05/12/2005US20050102712 Using chlorophyll biosynthesis enzyme as tool for identifying agents which enhance photosynthetic activity of plants
05/12/2005US20050101773 Genes required for viability and/or reproduction in c. elegans and their use in the development of anti-nematode agents
05/12/2005US20050101556 Genetic engineering; Alzheimer's disease; anticancer agents
05/12/2005US20050101529 Protein modification and maintenance molecules
05/12/2005US20050101020 Methods and products for delivering biological molecules to cells using multicomponent nanostructures
05/12/2005US20050101017 Using vector transformation to generate drug resistant embryonic stem cell; improving/enhancing heterologous gene expression
05/12/2005US20050101014 Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
05/12/2005US20050101012 CD4+CD25+ regulatory T cells from human blood
05/12/2005US20050101011 Serum free nutrient broth comprised of fructose for use in propagation of cells and improving recombinant and/or endogenous protein synthesis; bioreactors
05/12/2005US20050101010 Cell culture tool and method
05/12/2005US20050101004 Screening for a compound to inhibit the urge for urinary incontinence by detecting activation of KCNQ protein in the host cell; measuring the membrane potential of the host cell and selecting the compound whose presence causes hyperpolarization in themembrane potential of the host cell
05/12/2005US20050100985 Saturation mutagenesis in directed evolution
05/12/2005US20050100970 Method of affinity separation and ligands for use therein
05/12/2005US20050100957 Hybridoma cell lines for use in propagation of monoclonal antibodies for prevention and treatment of cell proliferative disorders; immunotherapy
05/12/2005US20050100918 Mammalian receptor proteins; related reagents and methods
05/12/2005US20050100917 Mammalian receptor proteins; related reagents and methods
05/12/2005US20050100913 RNA interference pathway genes as tools for targeted genetic interference
05/12/2005US20050100894 Novel mitogen activated kinase
05/12/2005US20050100882 Viral polypeptide fusion comprising guanylyltransferase, methyltransferase and polymerase activities for use as tool in identifying modulator of viral propagation; viricides
05/12/2005US20050100877 Biodegradable polymer-ligand conjugates and their uses in isolation of cellular subpolulations and in cryopreservation, culture and transplantation of cells
05/12/2005US20050100552 Baculovirus vector, expressed in insect cells; induce apoptosis; introduced into tumor cell by viral vector, liposome, a conjugate, injection, electroporation, particle bombardment
05/12/2005US20050100549 Regulation of cytotrophoblast cell differentiation and cell migration
05/12/2005US20050100547 Also a method for detecting an agent capable of binding TRAF2 binding site of sphingosine kinase by contacting cells with a putative agent and detecting an altered expression phenotype
05/12/2005US20050100545 Mutated antibody does not possess O-linked glycosylation, nucleic acids encoding prevents N-linked glycosylation; humanized and conjugated with radionucleotide to image target cells
05/12/2005US20050100544 Interleukin-8 homologous polypeptides and therapeutic uses thereof
05/12/2005US20050100540 Platelet-activating factor acetylhydrolase
05/12/2005US20050100536 Platelet rich plasma, no exogenous activator; sodium bicarbonate buffer, citrate dextrose anticoagulant
05/12/2005US20050100533 Promoting osteodifferentiation by coating a substrate with a solution of a synthetic peptide having -Ile-Ala residues folded in a beta-bend and mimics cell binding by collagen, incorporation into a biocompatible gel, exposure to cells; hard and soft tissue repair; dentistry
05/12/2005CA2558306A1 Three-dimensional mammalian ovarian follicular cell and ovarian follicle culture systems in a biocompatible matrix
05/12/2005CA2544786A1 Method for producing gene transferred dendritic cells
05/12/2005CA2544779A1 Hydrogel providing cell-specific ingrowth
1 ... 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 ... 1827